GREGORY JULIA P

SEC Form 4 insider trading activity

GREGORY JULIA P has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Oct 14, 2026.

On the most recent filing, GREGORY JULIA P is listed as Director at Nurix Therapeutics, Inc. Inside the rolling window, GREGORY JULIA P reported no open-market purchases and 1 open-market sale totaling $529K in NRIX.

Companies traded

Other insiders at NRIX

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$529K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
NRIX
GREGORY JULIA P
Sale$529KOct 14SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has GREGORY JULIA P made?

GREGORY JULIA P has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.

Which companies does GREGORY JULIA P trade?

GREGORY JULIA P has filed SEC Form 4 disclosures for 1 company, including NRIX.

When was GREGORY JULIA P's most recent SEC Form 4 filing?

GREGORY JULIA P's most recent SEC Form 4 filing on Tracefour is dated Oct 14, 2026.

What is GREGORY JULIA P's total buy and sell value in the current window?

Inside the rolling retention window, GREGORY JULIA P bought $0 and sold $529K based on SEC Form 4 filings.

What was GREGORY JULIA P's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 22,583 NRIX shares on 2026-10-14, worth $529K, per SEC Form 4 filings.